Table of Contents

1 Study Coverage

• 1.1 Hemodialysis Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Hemodialysis Market Size Growth Rate by Product
  • 1.4.2 Hemodialysis Machine (HD)
  • 1.4.3 Hemodiafiltration machine (HF)
  • 1.4.4 Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
• 1.5 Market by End User
  • 1.5.1 Global Hemodialysis Market Size Growth Rate by End User
  • 1.5.2 Acute renal failure
  • 1.5.3 Chronic renal failure
  • 1.5.4 Acute drug poisoning or poison
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Hemodialysis Market Size
  • 2.1.1 Global Hemodialysis Revenue 2014-2025
  • 2.1.2 Global Hemodialysis Sales 2014-2025
• 2.2 Hemodialysis Growth Rate by Regions
  • 2.2.1 Global Hemodialysis Sales by Regions
  • 2.2.2 Global Hemodialysis Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Hemodialysis Sales by Manufacturers
  • 3.1.1 Hemodialysis Sales by Manufacturers
  • 3.1.2 Hemodialysis Sales Market Share by Manufacturers
  • 3.1.3 Global Hemodialysis Market Concentration Ratio (CR5 and HHI)
• 3.2 Hemodialysis Revenue by Manufacturers
  • 3.2.1 Hemodialysis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Hemodialysis Revenue Share by Manufacturers (2014-2019)
• 3.3 Hemodialysis Price by Manufacturers
• 3.4 Hemodialysis Manufacturing Base Distribution, Product Types
  • 3.4.1 Hemodialysis Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Hemodialysis Product Type
  • 3.4.3 Date of International Manufacturers Enter into Hemodialysis Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Hemodialysis Sales by Product
• 4.2 Global Hemodialysis Revenue by Product
• 4.3 Hemodialysis Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Hemodialysis Breakdown Data by End User

6 North America

• 6.1 North America Hemodialysis by Countries
  • 6.1.1 North America Hemodialysis Sales by Countries
  • 6.1.2 North America Hemodialysis Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Hemodialysis by Product
• 6.3 North America Hemodialysis by End User

7 Europe

• 7.1 Europe Hemodialysis by Countries
  • 7.1.1 Europe Hemodialysis Sales by Countries
  • 7.1.2 Europe Hemodialysis Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Hemodialysis by Product
• 7.3 Europe Hemodialysis by End User

8 Asia Pacific

• 8.1 Asia Pacific Hemodialysis by Countries
  • 8.1.1 Asia Pacific Hemodialysis Sales by Countries
  • 8.1.2 Asia Pacific Hemodialysis Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Hemodialysis by Product
• 8.3 Asia Pacific Hemodialysis by End User

9 Central & South America

• 9.1 Central & South America Hemodialysis by Countries
  • 9.1.1 Central & South America Hemodialysis Sales by Countries
  • 9.1.2 Central & South America Hemodialysis Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Hemodialysis by Product
• 9.3 Central & South America Hemodialysis by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Hemodialysis by Countries
  • 10.1.1 Middle East and Africa Hemodialysis Sales by Countries
  • 10.1.2 Middle East and Africa Hemodialysis Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Hemodialysis by Product
• 10.3 Middle East and Africa Hemodialysis by End User

11 Company Profiles

• 11.1 Fresenius
  • 11.1.1 Fresenius Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Fresenius Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Fresenius Hemodialysis Products Offered
  • 11.1.5 Fresenius Recent Development
• 11.2 Baxter & Gambro
  • 11.2.1 Baxter & Gambro Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Baxter & Gambro Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Baxter & Gambro Hemodialysis Products Offered
  • 11.2.5 Baxter & Gambro Recent Development
• 11.3 B.Braum
  • 11.3.1 B.Braum Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 B.Braum Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 B.Braum Hemodialysis Products Offered
  • 11.3.5 B.Braum Recent Development
• 11.4 Nikkiso
  • 11.4.1 Nikkiso Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Nikkiso Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Nikkiso Hemodialysis Products Offered
  • 11.4.5 Nikkiso Recent Development
• 11.5 Toray
  • 11.5.1 Toray Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Toray Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Toray Hemodialysis Products Offered
  • 11.5.5 Toray Recent Development
• 11.6 Nipro
  • 11.6.1 Nipro Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Nipro Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Nipro Hemodialysis Products Offered
  • 11.6.5 Nipro Recent Development
• 11.7 Bellco
  • 11.7.1 Bellco Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Bellco Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Bellco Hemodialysis Products Offered
  • 11.7.5 Bellco Recent Development
• 11.8 Asahi Kasei
  • 11.8.1 Asahi Kasei Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Asahi Kasei Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Asahi Kasei Hemodialysis Products Offered
  • 11.8.5 Asahi Kasei Recent Development
• 11.9 WEGO
  • 11.9.1 WEGO Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 WEGO Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 WEGO Hemodialysis Products Offered
  • 11.9.5 WEGO Recent Development
• 11.10 Shanwaishan
  • 11.10.1 Shanwaishan Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Shanwaishan Hemodialysis Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Shanwaishan Hemodialysis Products Offered
  • 11.10.5 Shanwaishan Recent Development
• 11.11 Jihua

12 Future Forecast

• 12.1 Hemodialysis Market Forecast by Regions
  • 12.1.1 Global Hemodialysis Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Hemodialysis Revenue Forecast by Regions 2019-2025
• 12.2 Hemodialysis Market Forecast by Product
  • 12.2.1 Global Hemodialysis Sales Forecast by Product 2019-2025
  • 12.2.2 Global Hemodialysis Revenue Forecast by Product 2019-2025
• 12.3 Hemodialysis Market Forecast by End User
• 12.4 North America Hemodialysis Forecast
• 12.5 Europe Hemodialysis Forecast
• 12.6 Asia Pacific Hemodialysis Forecast
• 12.7 Central & South America Hemodialysis Forecast
• 12.8 Middle East and Africa Hemodialysis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Hemodialysis Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Hemodialysis is used for hemodialysis equipment. Referred to hemodialysis, also known as the popular saying artificial kidney, dialysis is a blood purification technology. The principle of using semi-permeable membrane, by diffusion, convection, and the body of harmful metabolic wastes and excess electrolytes too much out of the body, to achieve the purpose of purifying the blood and suck up water and electrolyte and acid-base balance correction purposes. According to the different treatment methods, divided into intermittent hemodialysis and continuous hemodialysis treatment. In addition to chronic renal failure replacement therapy used, but also widely used in different causes of acute renal failure, multiple organ failure, severe trauma, acute necrotizing pancreatitis, hyperkalemia, hypernatremia, acute alcoholism, etc. . Hemodialysis can reduce the symptoms and prolong survival time, and it is the effective measures to rescue of acute and chronic renal failure.
Hemodialysis Machine Price decreasing all these years as competition, and future price will continue decreasing as competition and technology Localization, while market demand of hemodialysis machine will increase at high speed for a long term.
Though Price and Profit both decrease, while its rapid increase of market demand, future Hemodialysis Machine Capacity Production will keep a high speed development.
Single Pump Hemodialysis Machine still the key model, Double Pump use rate will increase.
The global Hemodialysis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemodialysis market based on company, product type, end user and key regions.

This report studies the global market size of Hemodialysis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemodialysis in these regions.
This research report categorizes the global Hemodialysis market by top players/brands, region, type and end user. This report also studies the global Hemodialysis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Fresenius
Baxter & Gambro
B.Braum
Nikkiso
Toray
Nipro
Bellco
Asahi Kasei
WEGO
Shanwaishan
Jihua

Market size by Product
Hemodialysis Machine (HD)
Hemodiafiltration machine (HF)
Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
Market size by End User
Acute renal failure
Chronic renal failure
Acute drug poisoning or poison
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Hemodialysis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemodialysis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemodialysis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemodialysis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hemodialysis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemodialysis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.